CRIS Current Research Information System

MURATORI, PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.479
EU - Europa 4.219
AS - Asia 2.510
AF - Africa 257
OC - Oceania 16
SA - Sud America 13
Totale 13.494
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.460
GB - Regno Unito 1.264
CN - Cina 877
VN - Vietnam 751
IT - Italia 626
SE - Svezia 625
DE - Germania 576
SG - Singapore 546
UA - Ucraina 298
IN - India 249
RU - Federazione Russa 170
IE - Irlanda 165
FR - Francia 154
EE - Estonia 86
ZA - Sudafrica 82
TG - Togo 70
CH - Svizzera 64
CI - Costa d'Avorio 59
FI - Finlandia 45
BG - Bulgaria 34
JO - Giordania 28
BE - Belgio 24
NG - Nigeria 20
SC - Seychelles 20
CA - Canada 18
NL - Olanda 18
GR - Grecia 16
HR - Croazia 13
ID - Indonesia 12
AT - Austria 10
AU - Australia 10
IR - Iran 10
RO - Romania 8
JP - Giappone 7
TR - Turchia 7
NZ - Nuova Zelanda 6
PL - Polonia 6
CZ - Repubblica Ceca 5
HK - Hong Kong 5
PT - Portogallo 5
BR - Brasile 4
EG - Egitto 4
AR - Argentina 3
BD - Bangladesh 3
ES - Italia 3
MY - Malesia 3
CL - Cile 2
EC - Ecuador 2
KR - Corea 2
LB - Libano 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
AM - Armenia 1
BO - Bolivia 1
CY - Cipro 1
DK - Danimarca 1
FK - Isole Falkland (Malvinas) 1
IQ - Iraq 1
MA - Marocco 1
MX - Messico 1
NO - Norvegia 1
PH - Filippine 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
TW - Taiwan 1
Totale 13.494
Salva come PNG Salva come JPEG
Città #
Southend 1.129
Fairfield 828
Chandler 595
Dong Ket 585
Ashburn 515
Singapore 474
Woodbridge 402
Houston 390
Seattle 383
Santa Clara 361
Wilmington 352
Cambridge 294
Princeton 253
Ann Arbor 247
Jacksonville 193
Dublin 164
Boardman 153
Bologna 120
Nanjing 115
Padova 103
Westminster 101
Berlin 90
Jinan 83
Lomé 70
Abidjan 59
Shenyang 55
Saint Petersburg 53
Bern 52
San Diego 51
Beijing 45
Milan 41
Hebei 40
Helsinki 40
Bremen 39
Mülheim 39
Des Moines 38
Changsha 37
Nanchang 35
Sofia 32
Guangzhou 31
Turin 29
Amman 28
Tianjin 26
New York 25
Brussels 24
Medford 24
Haikou 21
Abeokuta 20
Hangzhou 20
Mahé 20
Falls Church 19
Jiaxing 19
Dearborn 18
Frankfurt am Main 18
Los Angeles 18
Rome 18
Taiyuan 18
Zhengzhou 18
Bühl 17
Fremont 15
Taizhou 15
Verona 15
Chengdu 14
Fuzhou 14
Ningbo 14
Shanghai 14
Olalla 13
Phoenix 13
Redwood City 13
Norwalk 12
Washington 12
London 11
Jakarta 10
Moscow 10
San Francisco 10
Vienna 10
Leawood 9
Toronto 9
Lanzhou 8
Wuhan 8
Modena 7
Mumbai 7
Paris 7
Parma 7
Tokyo 7
Amsterdam 6
Andover 6
Buffalo 6
Chongqing 6
Falkenstein 6
Florence 6
Fort Worth 6
Pontassieve 6
Qingdao 6
Xi'an 6
Botosani 5
Kunming 5
Mountain View 5
Ravenna 5
San Giorgio di Piano 5
Totale 9.456
Salva come PNG Salva come JPEG
Nome #
A multifaceted imbalance of T cells with regulatory function characterizes type 1 autoimmune hepatitis 221
Anti-Saccharomyces cerevisiae and perinuclear anti-neutrophil antibodies in coeliac disease before and after gluten free diet. 213
Antibodies to SS-A/Ro-52kD and centromere in autoimmune liver disease: a clue to diagnosis and prognosis of primary biliary cirrhosis. 192
Clinical and serological profile of primary biliary cirrhosis in men. 179
Type 1 autoimmune hepatitis: patterns of clinical presentation and differential diagnosis of the 'acute' type. 177
Clinical features of type 1 autoimmune hepatitis in elderly Italian patients 176
A COMPLEX IMMUNOREGULATORY DEFICIENCY CHARACTERISES TYPE 1 AUTOIMMUNE HEPATITIS. 172
Acute icteric hepatitis induced by a short course of low-dose cyclophosphamide in a patient with lupus nephritis 171
Application of the 2010 American Association for the study of liver diseases criteria of remission to a cohort of Italian patients with autoimmune hepatitis. 170
Antinuclear antibodies as ancillary markers in primary biliary cirrhosis. 168
Anti-actin IgA antibodies in severe coeliac disease 167
Autoimmune enteropathy and rheumatoid arthritis: A new association in the field of autoimmunity. 165
Multiple nuclear dots and rim-like/membranous IgG isotypes in primary biliary cirrhosis. 161
Imaging-based diagnosis of benign lesions and pseudolesions in the cirrhotic liver 161
Anti-nuclear antibodies giving the “multiple nuclear dots” (MND) or the “rim-like/membranous” (RL/M) patterns: diagnostic accuracy for primary biliary cirrhosis. 157
A case of leptospirosis simulating colon cancer with liver metastases 157
Antimitochondrial antibodies positive autoimmune hepatitis with acute onset 157
Clinical impact of non-organ-specific autoantibodies on the response to combined antiviral treatment in patients with hepatitis C 153
Autoimmune liver disease in patients with systemic lupus erythematosus: a retrospective analysis of 147 cases. 149
Antibodies to filamentous actin (F-actin) in type 1 autoimmune hepatitis. 149
'True' antimitochondrial antibody-negative primary biliary cirrhosis, low sensitivity of the routine assays, or both? 148
SPECIFICITY OF ANTI-SP100 ANTIBODY FOR PRIMARY BILIARY CIRRHOSIS. 148
Antinuclear antibodies in COVID 19 144
Autoimmune liver disease and concomitant extrahepatic autoimmune disease 143
Autoantibodies in Autoimmune Hepatitis 142
Autoimmune liver disease 2007. 140
Diagnosis and therapy of autoimmune hepatitis. 139
Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis 137
Antifilamentous Actin Antibodies by ELISA for the Diagnosis of Type 1 Autoimmune Hepatitis. 137
Virological analysis, genotypes and mutational patterns of the HBV pre-core/core gene in HBV/HCV-related hepatocellular carcinoma. 137
CLINICAL FEATURES OF PRIMARY BILIARY CIRRHOSIS IN YOUNG AND ELDERLY PATIENTS. 135
PML nuclear body component Sp140 is a novel autoantigen in primary biliary cirrhosis. 134
Clinical implications of antimitochondrial antibody seropositivity in autoimmune hepatitis: a multicentre study 134
Clinical and serological profile of primary biliary cirrhosis in young and elderly patients. 133
Autoimmune hepatitis in Italy: the Bologna experience. 132
Deamidated gliadin Peptide antibodies as a routine test for celiac disease: a prospective analysis. 131
Antitransglutaminase antibodies and giardiasis 131
The western immunoblotting pattern of anti-mitochondrial antibodies is independent of the clinical expression of primary biliary cirrhosis 131
Anti-ribosomal P protein antibody: an autoreactivity devoid of prognostic value in patients with autoimmune hepatitis. 130
Imbalance of Neutrophils and Lymphocyte Counts Can Be Predictive of Hepatocellular Carcinoma Occurrence in Hepatitis C-related Cirrhosis Treated With Direct-acting Antivirals 130
Antibodies to soluble liver antigen in patients with various liver diseases: A multicentre study 129
Type 1 and type 2 autoimmune hepatitis in adults share the same clinical phenotype 129
Clinical Impact and behaviour of serum autoantibodies in adult liver transplantation 129
Clinical features and effect of antiviral therapy on anti-liver/kidney microsomal antibody type 1 positive chronic hepatitis C. 128
Anti-saccharomyces cerevisiae antibodies (ASCA) in coeliac disease. 127
Antimitochondrial antibodies and other antibodies in primary biliary cirrhosis: diagnostic and prognostic value 127
Features and Progression of Asymptomatic Autoimmune Hepatitis in Italy 127
Direct acting antivirals for the treatment of elderly patients with HCV advanced disease in the real life practice 127
Clinical and prognostic implications of acute onset of Autoimmune Hepatitis: An Italian multicentre study 124
Treatment with direct acting antiviral agents-based regimen in HCV patients with advanced liver disease: Analysis of an Italian multicenter observational study 123
Evidence of a genetic basis for the different geographic occurrences of liver/kidney microsomal antibody type 1 in hepatitis C. 121
COVID-19 and Immunological Dysregulation: Can Autoantibodies be Useful? 119
The serological profile of the autoimmune hepatitis/primary biliary cirrhosis overlap syndrome. 117
Immunoglobulin GM and KM allotypes and prevalence of anti-LKM1 autoantibodies in patients with hepatitis C virus infection. 116
Redistribution of regulatory T-cells across the evolving stages of chronic hepatitis C. 116
Overcoming a "probable" diagnosis in antimitochondrial antibody negative primary biliary cirrhosis: study of 100 sera and review of the literature. 113
Diagnostic and therapeutic implications of bile duct injury in autoimmune hepatitis. 112
PML NUCLEAR BODY COMPONENT SP140 IS A NOVEL AUTOANTIGEN IN PRIMARY BILIARY CIRRHOSIS. 111
Primary biliary cirrhosis specific anti-nuclear antibodies in patients from Spain. 110
Diagnostic approach to autoimmune hepatitis 110
Celiac disease in autoimmune cholestatic liver disorders 108
Standardization of Autoantibody Testing in Autoimmune Hepatitis 107
Multiple viral/self immunological cross-reactivity in liver kidney microsomal antibody positive hepatitis C virus infected patients is associated with the possession of HLA B51 106
Classical HLA-DRB1 and DPB1 alleles account for HLA associations with primary biliary cirrhosis. 105
Efficacy and Safety of Mycophenolate Mofetil and Tacrolimus as Second-line Therapy for Patients With Autoimmune Hepatitis. 105
Specific antinuclear reactivities in primary biliary cirrhosis 104
Autoantibodies in antimithocondrial antibodies negative primary biliary cholangitis. 103
Factors associated with response to therapy and outcome of patients with primary biliary cirrhosis with features of autoimmune hepatitis. 102
Hepatic steatosis in chronic hepatitis C: impact on response to anti-viral treatment with peg-interferon and ribavirin 101
INCREASED REGULATORY POTENTIAL AND IMBALANCE OF THE VDELTA1/VDELTA2 RATIO IN PATIENTS WITH DIFFERENT MANIFESTATIONS OF HEPATITIS C. 101
Pathway-based analysis of primary biliary cirrhosis genome-wide association studies 99
Autoimmune hepatitis/primary biliary cirrhosis overlap syndrome and associated extrahepatic autoimmune diseases. 98
Serum Smooth Muscle Antibodies (SMA). 97
Usefulness of Antibodies to Deamidated Gliadin Peptides in Celiac Disease Diagnosis and Follow-up. 97
Diagnosis of primary biliary cholangitis in a "teen" male patient 97
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs 97
null 96
DETECTION OF MND AND RL/M ANTI-NUCLEAR ANTIBODIES PATTERNS: A RELIABLE DIAGNOSTIC TOOL IN ANTI-MITOCHONDRIAL ANTIBODIES NEGATIVE PRIMARY BILIARY CIRRHOSIS. 96
Response to Efe et al. 95
null 92
Hepatitis C and autoreactivity. 90
Identification of new autoantigens by protein array indicates a role for IL4 neutralization in Autoimmune Hepatitis. 90
International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways 90
Le fonti energetiche rinnovabili nel contesto internazionale: il solare fotovoltaico ed i suoi sviluppi tecnologici 88
Review article: autoimmune hepatitis - current management and challenges 88
Tacrolimus and Mycophenolate Mofetil as Second-Line Therapies for Pediatric Patients with Autoimmune Hepatitis 87
Current topics in autoimmune hepatitis. 87
Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variants. 86
Non organ specific autoantibodies in children with chronic hepatitis C virus infection 86
Numerical investigation of blood flow in a stenotic artery. Target 1: geometry and rheology 82
Genetic distinction between autoimmune hepatitis in Italy and North America 82
Smooth Muscle Antibodies 81
Susceptibility to thyroid disorders in hepatitis C 81
Hepatocellular carcinoma in viral and autoimmune liver diseases: Role of CD4+ CD25+ Foxp3+ regulatory T cells in the immune microenvironment 80
Sequential presentation of primary biliary cirrhosis and autoimmune hepatitis. 78
Diagnostic difficulties, therapeutic strategies, and performance of scoring systems in patients with autoimmune hepatitis and concurrent hepatitis B/C 76
Validation of simplified diagnostic criteria for autoimmune hepatitis in Italian patients. 76
LKM1-positive type 2 autoimmune hepatitis following allogenic haematopoietic stem-cell transplantation. 74
Liver fibrosis may reduce the efficacy of budesonide in the treatment of autoimmune hepatitis and overlap syndrome. 73
Autoantibodies to enterocytes in patients with villous atrophy unresponsive to gluten free diet. 73
Totale 12.220
Salva come PNG Salva come JPEG
Categoria #
all - tutte 37.334
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.334
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.213 0 0 0 0 0 341 386 413 430 273 166 204
2020/20212.187 327 125 61 79 70 103 56 186 132 129 92 827
2021/20222.455 211 49 169 220 201 124 50 168 100 177 567 419
2022/20232.442 326 342 128 314 139 186 87 135 388 95 189 113
2023/2024667 48 112 44 67 61 98 32 55 22 33 49 46
2024/20251.689 156 422 292 211 485 123 0 0 0 0 0 0
Totale 13.761